r (v 4.1.2) software Search Results


90
GraphPad Software Inc r statistical software (version 4.1.2
R Statistical Software (Version 4.1.2, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/r+%28v+4%2E1%2E2%29+software/pm36976907-496-6-13?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
r statistical software (version 4.1.2 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
RStudio integrated development free software r-studio version 4.1.2
Integrated Development Free Software R Studio Version 4.1.2, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/r+%28v+4%2E1%2E2%29+software/10__1021_slash_acsfoodscitech__3c00622-96-7-11?v=RStudio
Average 90 stars, based on 1 article reviews
integrated development free software r-studio version 4.1.2 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Becton Dickinson facsdiva software v 4.1.2
Facsdiva Software V 4.1.2, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/r+%28v+4%2E1%2E2%29+software/pmc03115142-69-22-21?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
facsdiva software v 4.1.2 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc r software v 4.1.2
R Software V 4.1.2, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/r+%28v+4%2E1%2E2%29+software/pmc11176334-102-5-23?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
r software v 4.1.2 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
RStudio r software environment for statistical computing and graphics version 4.1.2
R Software Environment For Statistical Computing And Graphics Version 4.1.2, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/r+%28v+4%2E1%2E2%29+software/pm39549095-60-12-16?v=RStudio
Average 90 stars, based on 1 article reviews
r software environment for statistical computing and graphics version 4.1.2 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
RStudio arima (p, d, q) model using rstudio v.4.1.2 software
Arima (P, D, Q) Model Using Rstudio V.4.1.2 Software, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/r+%28v+4%2E1%2E2%29+software/pmc08993143-113-27-26?v=RStudio
Average 90 stars, based on 1 article reviews
arima (p, d, q) model using rstudio v.4.1.2 software - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
RStudio r for mac os 4.1.2 statistical software
R For Mac Os 4.1.2 Statistical Software, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/r+%28v+4%2E1%2E2%29+software/pm36203312-128-8-13?v=RStudio
Average 90 stars, based on 1 article reviews
r for mac os 4.1.2 statistical software - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
RStudio r software for windows 4.1.2
R Software For Windows 4.1.2, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/r+%28v+4%2E1%2E2%29+software/pmc10018277-120-3-9?v=RStudio
Average 90 stars, based on 1 article reviews
r software for windows 4.1.2 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
KNIME GmbH v. 4.1.2 software
V. 4.1.2 Software, supplied by KNIME GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/r+%28v+4%2E1%2E2%29+software/pmc08590336-78-6-7?v=KNIME+GmbH
Average 90 stars, based on 1 article reviews
v. 4.1.2 software - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Amerinex Inc software apheliontm v.4.1.2
Software Apheliontm V.4.1.2, supplied by Amerinex Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/r+%28v+4%2E1%2E2%29+software/10__1016_slash_j__indcrop__2013__11__022-89-28-32?v=Amerinex+Inc
Average 90 stars, based on 1 article reviews
software apheliontm v.4.1.2 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
RStudio boxplot function in r studio software 4.1.2
a Experimental timeline. Dyskinetic mice (LID, magenta): 6 weeks of levodopa treatment. Preventive mice (LID_PREV, blue): 6 weeks of levodopa treatment + 4 weeks of cerebellar stimulation. Corrective mice (LID_CORR, green): 6 weeks of levodopa treatment + 2 weeks of cerebellar stimulation. AIMs corresponds to the evaluation of Abnormal Involuntary Movements (LID). b Sagittal schematic of a mouse brain showing cerebello-thalamo-cortical and -striatal pathways, ChR2-YFP in Purkinje cells (PC + ChR2, green), and injection site of 6-OHDA or saline. M1: Primary motor cortex, ST: striatum, VAL: Ventroanterior-ventrolateral complex of the thalamus, PF: Parafascicular nucleus of the thalamus, SNc: Substantia nigra pars compacta , CN: cerebellar nuclei, CrusII: Crus2 of the ansiform lobule. c Upper panel : Coronal section from a mouse unilaterally-lesioned with 6-OHDA stained with anti-tyrosine hydroxylase (TH). Scale bar: 0.5 mm. Bottom panel : Boxplot showing the average loss of striatal TH-positive fibers (%) between the lesioned and the intact striatum in SHAM (gray, N = 17), LID (magenta, N = 13), LID_CORR (green, N = 10), and LID_PREV (blue, N = 17). d Examples of orolingual (top), axial (middle), and limb (bottom) levodopa-induced dyskinesia in dyskinetic mice. e Boxplot showing the sum of oral LID scores across the 6 weeks of levodopa treatment (6 mg/kg) (light gray bar) for SHAM ( N = 18), LID ( N = 19); LID_CORR ( N = 17); LID_PREV ( N = 24). f Boxplot showing the sum of axial LID across the 6 weeks of levodopa treatment (6 mg/kg) (light gray bar) for SHAM ( N = 12), LID ( N = 8), LID_CORR ( N = 14), LID_PREV ( N = 6). g Boxplot showing the sum of limb LID scores across the 6 weeks of levodopa treatment (6 mg/kg) (light gray bar) for SHAM (N = 14), LID ( N = 9), LID_CORR ( N = 15), LID_PREV ( N = 9). <t>Boxplots</t> represents the lower and the upper quartiles as well as the median of LID score. Each boxplot corresponds to 1 week. Vertical lines represent the median ± the standard deviation. Isolated points represent outliers of the distribution. Stripped blue lines: weeks of theta-burst PC stimulation. Kruskal-Wallis test with pairwise two-sided Wilcoxon test and Benjamini & Hochberg correction. *** p < 0.001; ** p < 0.01; * p < 0.05; * compared to SHAM; # to LID. Source data are provided as a Source Data file. See also Table .
Boxplot Function In R Studio Software 4.1.2, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/r+%28v+4%2E1%2E2%29+software/pmc09184492-465-7-12?v=RStudio
Average 90 stars, based on 1 article reviews
boxplot function in r studio software 4.1.2 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Becton Dickinson fluorescence-activated cell sorting diva software v.4.1.2
a Experimental timeline. Dyskinetic mice (LID, magenta): 6 weeks of levodopa treatment. Preventive mice (LID_PREV, blue): 6 weeks of levodopa treatment + 4 weeks of cerebellar stimulation. Corrective mice (LID_CORR, green): 6 weeks of levodopa treatment + 2 weeks of cerebellar stimulation. AIMs corresponds to the evaluation of Abnormal Involuntary Movements (LID). b Sagittal schematic of a mouse brain showing cerebello-thalamo-cortical and -striatal pathways, ChR2-YFP in Purkinje cells (PC + ChR2, green), and injection site of 6-OHDA or saline. M1: Primary motor cortex, ST: striatum, VAL: Ventroanterior-ventrolateral complex of the thalamus, PF: Parafascicular nucleus of the thalamus, SNc: Substantia nigra pars compacta , CN: cerebellar nuclei, CrusII: Crus2 of the ansiform lobule. c Upper panel : Coronal section from a mouse unilaterally-lesioned with 6-OHDA stained with anti-tyrosine hydroxylase (TH). Scale bar: 0.5 mm. Bottom panel : Boxplot showing the average loss of striatal TH-positive fibers (%) between the lesioned and the intact striatum in SHAM (gray, N = 17), LID (magenta, N = 13), LID_CORR (green, N = 10), and LID_PREV (blue, N = 17). d Examples of orolingual (top), axial (middle), and limb (bottom) levodopa-induced dyskinesia in dyskinetic mice. e Boxplot showing the sum of oral LID scores across the 6 weeks of levodopa treatment (6 mg/kg) (light gray bar) for SHAM ( N = 18), LID ( N = 19); LID_CORR ( N = 17); LID_PREV ( N = 24). f Boxplot showing the sum of axial LID across the 6 weeks of levodopa treatment (6 mg/kg) (light gray bar) for SHAM ( N = 12), LID ( N = 8), LID_CORR ( N = 14), LID_PREV ( N = 6). g Boxplot showing the sum of limb LID scores across the 6 weeks of levodopa treatment (6 mg/kg) (light gray bar) for SHAM (N = 14), LID ( N = 9), LID_CORR ( N = 15), LID_PREV ( N = 9). <t>Boxplots</t> represents the lower and the upper quartiles as well as the median of LID score. Each boxplot corresponds to 1 week. Vertical lines represent the median ± the standard deviation. Isolated points represent outliers of the distribution. Stripped blue lines: weeks of theta-burst PC stimulation. Kruskal-Wallis test with pairwise two-sided Wilcoxon test and Benjamini & Hochberg correction. *** p < 0.001; ** p < 0.01; * p < 0.05; * compared to SHAM; # to LID. Source data are provided as a Source Data file. See also Table .
Fluorescence Activated Cell Sorting Diva Software V.4.1.2, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/r+%28v+4%2E1%2E2%29+software/pm24398881-60-15-20?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
fluorescence-activated cell sorting diva software v.4.1.2 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


a Experimental timeline. Dyskinetic mice (LID, magenta): 6 weeks of levodopa treatment. Preventive mice (LID_PREV, blue): 6 weeks of levodopa treatment + 4 weeks of cerebellar stimulation. Corrective mice (LID_CORR, green): 6 weeks of levodopa treatment + 2 weeks of cerebellar stimulation. AIMs corresponds to the evaluation of Abnormal Involuntary Movements (LID). b Sagittal schematic of a mouse brain showing cerebello-thalamo-cortical and -striatal pathways, ChR2-YFP in Purkinje cells (PC + ChR2, green), and injection site of 6-OHDA or saline. M1: Primary motor cortex, ST: striatum, VAL: Ventroanterior-ventrolateral complex of the thalamus, PF: Parafascicular nucleus of the thalamus, SNc: Substantia nigra pars compacta , CN: cerebellar nuclei, CrusII: Crus2 of the ansiform lobule. c Upper panel : Coronal section from a mouse unilaterally-lesioned with 6-OHDA stained with anti-tyrosine hydroxylase (TH). Scale bar: 0.5 mm. Bottom panel : Boxplot showing the average loss of striatal TH-positive fibers (%) between the lesioned and the intact striatum in SHAM (gray, N = 17), LID (magenta, N = 13), LID_CORR (green, N = 10), and LID_PREV (blue, N = 17). d Examples of orolingual (top), axial (middle), and limb (bottom) levodopa-induced dyskinesia in dyskinetic mice. e Boxplot showing the sum of oral LID scores across the 6 weeks of levodopa treatment (6 mg/kg) (light gray bar) for SHAM ( N = 18), LID ( N = 19); LID_CORR ( N = 17); LID_PREV ( N = 24). f Boxplot showing the sum of axial LID across the 6 weeks of levodopa treatment (6 mg/kg) (light gray bar) for SHAM ( N = 12), LID ( N = 8), LID_CORR ( N = 14), LID_PREV ( N = 6). g Boxplot showing the sum of limb LID scores across the 6 weeks of levodopa treatment (6 mg/kg) (light gray bar) for SHAM (N = 14), LID ( N = 9), LID_CORR ( N = 15), LID_PREV ( N = 9). Boxplots represents the lower and the upper quartiles as well as the median of LID score. Each boxplot corresponds to 1 week. Vertical lines represent the median ± the standard deviation. Isolated points represent outliers of the distribution. Stripped blue lines: weeks of theta-burst PC stimulation. Kruskal-Wallis test with pairwise two-sided Wilcoxon test and Benjamini & Hochberg correction. *** p < 0.001; ** p < 0.01; * p < 0.05; * compared to SHAM; # to LID. Source data are provided as a Source Data file. See also Table .

Journal: Nature Communications

Article Title: Cerebellar stimulation prevents Levodopa-induced dyskinesia in mice and normalizes activity in a motor network

doi: 10.1038/s41467-022-30844-0

Figure Lengend Snippet: a Experimental timeline. Dyskinetic mice (LID, magenta): 6 weeks of levodopa treatment. Preventive mice (LID_PREV, blue): 6 weeks of levodopa treatment + 4 weeks of cerebellar stimulation. Corrective mice (LID_CORR, green): 6 weeks of levodopa treatment + 2 weeks of cerebellar stimulation. AIMs corresponds to the evaluation of Abnormal Involuntary Movements (LID). b Sagittal schematic of a mouse brain showing cerebello-thalamo-cortical and -striatal pathways, ChR2-YFP in Purkinje cells (PC + ChR2, green), and injection site of 6-OHDA or saline. M1: Primary motor cortex, ST: striatum, VAL: Ventroanterior-ventrolateral complex of the thalamus, PF: Parafascicular nucleus of the thalamus, SNc: Substantia nigra pars compacta , CN: cerebellar nuclei, CrusII: Crus2 of the ansiform lobule. c Upper panel : Coronal section from a mouse unilaterally-lesioned with 6-OHDA stained with anti-tyrosine hydroxylase (TH). Scale bar: 0.5 mm. Bottom panel : Boxplot showing the average loss of striatal TH-positive fibers (%) between the lesioned and the intact striatum in SHAM (gray, N = 17), LID (magenta, N = 13), LID_CORR (green, N = 10), and LID_PREV (blue, N = 17). d Examples of orolingual (top), axial (middle), and limb (bottom) levodopa-induced dyskinesia in dyskinetic mice. e Boxplot showing the sum of oral LID scores across the 6 weeks of levodopa treatment (6 mg/kg) (light gray bar) for SHAM ( N = 18), LID ( N = 19); LID_CORR ( N = 17); LID_PREV ( N = 24). f Boxplot showing the sum of axial LID across the 6 weeks of levodopa treatment (6 mg/kg) (light gray bar) for SHAM ( N = 12), LID ( N = 8), LID_CORR ( N = 14), LID_PREV ( N = 6). g Boxplot showing the sum of limb LID scores across the 6 weeks of levodopa treatment (6 mg/kg) (light gray bar) for SHAM (N = 14), LID ( N = 9), LID_CORR ( N = 15), LID_PREV ( N = 9). Boxplots represents the lower and the upper quartiles as well as the median of LID score. Each boxplot corresponds to 1 week. Vertical lines represent the median ± the standard deviation. Isolated points represent outliers of the distribution. Stripped blue lines: weeks of theta-burst PC stimulation. Kruskal-Wallis test with pairwise two-sided Wilcoxon test and Benjamini & Hochberg correction. *** p < 0.001; ** p < 0.01; * p < 0.05; * compared to SHAM; # to LID. Source data are provided as a Source Data file. See also Table .

Article Snippet: Unless otherwise stated, data are presented as boxplots (from boxplot function in R Studio software 4.1.2).

Techniques: Injection, Saline, Staining, Standard Deviation, Isolation

a Left : Experimental timeline. Right : Schematic of electrode implantation in the interposed nucleus (IN), ChR2-YFP expression in Purkinje cells (PC + ChR2, green) and injection site of 6-OHDA or saline. ST: Striatum; SNc: substantia nigra pars compacta ; M1: Primary motor cortex; PF: Parafascicular nucleus of the thalamus. b Left : Coronal section from L7-ChR2-YFP mouse. Red lines: electrode’s trajectory. Dotted white lines: IN, dentate (DN), and fastigial (FN) nuclei. Scale bar: 0.5 mm. Crus2: Crus2 of the ansiform lobule. Right : PC expressing YFP. Scale bar: 20 µm. c Top : Theta-burst protocol. Middle : Raster plot of a cerebellar nuclei (CN) neuron for each stimulation. Dotted line: Basal firing rate (FR) before the onset of stimulation. Blue box: Time of optogenetic stimulation. Bottom : Summary of CN firing profiles ( n = 27; N = 3) exhibiting a strong inhibition (>90%) during PC stimulation. The firing rate of each unit was normalized to its baseline. Shaded lines: mean ± the standard deviation (std). d Examples of raw traces recorded in IN in LID ( top ) and SHAM ( bottom ) and their associated spike shape. e Firing rate (Hz) across 9 weeks in IN. Boxplots show the median (horizontal bars) over 4 categories of weeks. First boxplot: 2 nd and 3 rd weeks; second boxplot: 4th and 5th weeks when levodopa begins; third boxplot: 6th and 7th weeks; last boxplot: 8th and 9th weeks when stimulation stopped. f Coefficient of variation 2 (cv2.isi) across 9 weeks in IN. Same order of boxplot as panel e . Gray = SHAM ( N = 5); Magenta = LID ( N = 3); Blue = LID_PREV ( N = 4). Light gray lines: 6 weeks of levodopa treatment (3 boxplots; 6 mg/kg). Stripped blue lines: weeks of theta-burst stimulation. Boxplot represents the lower and the upper quartiles as well as the median rate (horizontal bars). Vertical lines represent the median ± std. Isolated points represent outliers of the distribution. Welch Anova with two-sided Games Howell post-hoc test and one-way Anova’s with two-sided Tukey post-hoc test based on Levene test. *** p < 0.001; ** p < 0.01; * p < 0.05; ns: p > 0.5. Source data are provided as a Source Data file. See also Tables – .

Journal: Nature Communications

Article Title: Cerebellar stimulation prevents Levodopa-induced dyskinesia in mice and normalizes activity in a motor network

doi: 10.1038/s41467-022-30844-0

Figure Lengend Snippet: a Left : Experimental timeline. Right : Schematic of electrode implantation in the interposed nucleus (IN), ChR2-YFP expression in Purkinje cells (PC + ChR2, green) and injection site of 6-OHDA or saline. ST: Striatum; SNc: substantia nigra pars compacta ; M1: Primary motor cortex; PF: Parafascicular nucleus of the thalamus. b Left : Coronal section from L7-ChR2-YFP mouse. Red lines: electrode’s trajectory. Dotted white lines: IN, dentate (DN), and fastigial (FN) nuclei. Scale bar: 0.5 mm. Crus2: Crus2 of the ansiform lobule. Right : PC expressing YFP. Scale bar: 20 µm. c Top : Theta-burst protocol. Middle : Raster plot of a cerebellar nuclei (CN) neuron for each stimulation. Dotted line: Basal firing rate (FR) before the onset of stimulation. Blue box: Time of optogenetic stimulation. Bottom : Summary of CN firing profiles ( n = 27; N = 3) exhibiting a strong inhibition (>90%) during PC stimulation. The firing rate of each unit was normalized to its baseline. Shaded lines: mean ± the standard deviation (std). d Examples of raw traces recorded in IN in LID ( top ) and SHAM ( bottom ) and their associated spike shape. e Firing rate (Hz) across 9 weeks in IN. Boxplots show the median (horizontal bars) over 4 categories of weeks. First boxplot: 2 nd and 3 rd weeks; second boxplot: 4th and 5th weeks when levodopa begins; third boxplot: 6th and 7th weeks; last boxplot: 8th and 9th weeks when stimulation stopped. f Coefficient of variation 2 (cv2.isi) across 9 weeks in IN. Same order of boxplot as panel e . Gray = SHAM ( N = 5); Magenta = LID ( N = 3); Blue = LID_PREV ( N = 4). Light gray lines: 6 weeks of levodopa treatment (3 boxplots; 6 mg/kg). Stripped blue lines: weeks of theta-burst stimulation. Boxplot represents the lower and the upper quartiles as well as the median rate (horizontal bars). Vertical lines represent the median ± std. Isolated points represent outliers of the distribution. Welch Anova with two-sided Games Howell post-hoc test and one-way Anova’s with two-sided Tukey post-hoc test based on Levene test. *** p < 0.001; ** p < 0.01; * p < 0.05; ns: p > 0.5. Source data are provided as a Source Data file. See also Tables – .

Article Snippet: Unless otherwise stated, data are presented as boxplots (from boxplot function in R Studio software 4.1.2).

Techniques: Expressing, Injection, Saline, Inhibition, Standard Deviation, Isolation

a Top : Experimental timeline. Bottom : Schematic of electrode implantation in the primary motor cortex (M1) and the parafascicular nucleus of the thalamus (PF), ChR2-YFP expression in the Purkinje cells (PC + ChR2, green), and injection site of 6-OHDA or saline. ST: Striatum; SNc: substantia nigra pars compacta ; CN: cerebellar nuclei: VAL: Ventroanterior-ventrolateral complex of the thalamus. b Top: Coronal section from L7-ChR2-YFP mouse showing the electrode’s trajectory (dotted yellow line) and the lesion site (red circle) in layer 5 of oM1. Scale bar: 0.5 mm. Bottom: Coronal section from L7-ChR2-YFP mouse showing the electrode’s trajectory (dotted yellow line) and the lesion site (red circle) in PF. Scale bar: 0.5 mm. c Firing rate (Hz) across 9 weeks in M1. Boxplots show the median rate (horizontal bars), over 4 categories of weeks. First boxplot: 2nd and 3rd week of the protocol, second boxplot: 4th and 5th weeks when levodopa begins, third boxplot: 6th and 7th weeks, last boxplot: 8th of the protocol when stimulation stopped. Gray = SHAM ( N = 5); Magenta = LID ( N = 4); Blue = LID_PREV ( N = 8). Light gray lines: 6 weeks of levodopa treatment (3 boxplots; 6 mg/kg). Stripped blue lines: weeks of theta-burst stimulation. d Firing rate (Hz) across 9 weeks in PF. Same order of boxplot as panel c Gray = SHAM ( N = 5); Magenta = LID ( N = 4); Blue = LID_PREV ( N = 8). Light gray lines: 6 weeks of levodopa treatment (3 boxplots; 6 mg/kg). Stripped blue lines: weeks of theta-burst stimulation. Boxplot represents the lower and the upper quartiles as well as the median of the firing rate (horizontal bars). Vertical lines represent the median ± std. Isolated points represent outliers of the distribution. One-way Anova with two-sided Tukey HSD post-hoc test. *** p < 0.001; ** p < 0.01; * p < 0.05; ns: p > 0.5. Source data are provided as a Source Data file. See also Tables and .

Journal: Nature Communications

Article Title: Cerebellar stimulation prevents Levodopa-induced dyskinesia in mice and normalizes activity in a motor network

doi: 10.1038/s41467-022-30844-0

Figure Lengend Snippet: a Top : Experimental timeline. Bottom : Schematic of electrode implantation in the primary motor cortex (M1) and the parafascicular nucleus of the thalamus (PF), ChR2-YFP expression in the Purkinje cells (PC + ChR2, green), and injection site of 6-OHDA or saline. ST: Striatum; SNc: substantia nigra pars compacta ; CN: cerebellar nuclei: VAL: Ventroanterior-ventrolateral complex of the thalamus. b Top: Coronal section from L7-ChR2-YFP mouse showing the electrode’s trajectory (dotted yellow line) and the lesion site (red circle) in layer 5 of oM1. Scale bar: 0.5 mm. Bottom: Coronal section from L7-ChR2-YFP mouse showing the electrode’s trajectory (dotted yellow line) and the lesion site (red circle) in PF. Scale bar: 0.5 mm. c Firing rate (Hz) across 9 weeks in M1. Boxplots show the median rate (horizontal bars), over 4 categories of weeks. First boxplot: 2nd and 3rd week of the protocol, second boxplot: 4th and 5th weeks when levodopa begins, third boxplot: 6th and 7th weeks, last boxplot: 8th of the protocol when stimulation stopped. Gray = SHAM ( N = 5); Magenta = LID ( N = 4); Blue = LID_PREV ( N = 8). Light gray lines: 6 weeks of levodopa treatment (3 boxplots; 6 mg/kg). Stripped blue lines: weeks of theta-burst stimulation. d Firing rate (Hz) across 9 weeks in PF. Same order of boxplot as panel c Gray = SHAM ( N = 5); Magenta = LID ( N = 4); Blue = LID_PREV ( N = 8). Light gray lines: 6 weeks of levodopa treatment (3 boxplots; 6 mg/kg). Stripped blue lines: weeks of theta-burst stimulation. Boxplot represents the lower and the upper quartiles as well as the median of the firing rate (horizontal bars). Vertical lines represent the median ± std. Isolated points represent outliers of the distribution. One-way Anova with two-sided Tukey HSD post-hoc test. *** p < 0.001; ** p < 0.01; * p < 0.05; ns: p > 0.5. Source data are provided as a Source Data file. See also Tables and .

Article Snippet: Unless otherwise stated, data are presented as boxplots (from boxplot function in R Studio software 4.1.2).

Techniques: Expressing, Injection, Saline, Isolation

a Experimental timeline. b Schematic of mouse coronal sections showing the injection site of the retrograde CAV2-Cre-GFP in the parafascicular nucleus (PF, green) ipsilateral-to-the-lesion ( top, left ) and the injection site of the anterograde Cre-dependent pAAV-hSyn-DIO-hM4Di-mCherry in the three cerebellar nuclei (CN, red) contralateral-to-the-lesion. c Coronal section showing the injection site of retrograde CAV2-Cre-GFP in PF. Red dotted lines: needle’s trajectory. White dotted lines: limits of PF. Scale bar: 100 μm. d Coronal section showing the expression of anterograde hM4Di-mCherry in neurons (red) of CN. FN: fastigial nucleus; INant: interposed nucleus, anterior part; InDL: interposed nucleus, dorsolateral hump; Lat: lateral nucleus. Blue = DAPI; green = GFP and YFP; Red = mCherry. Scale bar: 100 μm. Insert: Postmortem histology showing hM4Di-mCherry-expressing neurons in (i) FN, (ii) IN, and (iii) DN. Scale bars: 20 µm. e Top . Pie chart representing the proportions of neurons in CN expressing hM4Di-mCherry (in magenta) and projecting to PF compared to other types of cells (in blue). Bottom . Boxplots showing the average distribution (in %) of the neurons expressing hM4Di-mCherry over the total number of cells (Ratio) in control animals (non-virally injected animals, in gray) and preventive animals either treated with saline (light blue) or CNO (dark blue). Gray dots represent individual data points present in the distribution f Boxplots showing the average scored of oral LID severity at the point time corresponding to 40 min after levodopa injection, 50 min after CNO injection and after theta-burst stimulations. Averaged score comprises the 4 weeks of cerebellar stimulation in two groups: preventive animals receiving saline (LID_PREV saline, N = 5), dark blue represents preventive animals receiving CNO (LID_PREV CNO, N = 6). Boxplots represent the median score (horizontal bars), the lower and the upper quartiles. Vertical lines represent median ± std. One-way Anova with two-sided Tukey HSD post-hoc test was used for 5e and non-parametric Kruskal-Wallis test with pairwise two-sided Wilcoxon test and a Benjamini & Hochberg correction were used for 5f. *** p < 0.001; ** p < 0.01; * p < 0.05; ns: p > 0.05. Source data are provided as a Source Data file. Schemes were taken from Franklin and Paxinos Brain Atlas, 3rd edition.

Journal: Nature Communications

Article Title: Cerebellar stimulation prevents Levodopa-induced dyskinesia in mice and normalizes activity in a motor network

doi: 10.1038/s41467-022-30844-0

Figure Lengend Snippet: a Experimental timeline. b Schematic of mouse coronal sections showing the injection site of the retrograde CAV2-Cre-GFP in the parafascicular nucleus (PF, green) ipsilateral-to-the-lesion ( top, left ) and the injection site of the anterograde Cre-dependent pAAV-hSyn-DIO-hM4Di-mCherry in the three cerebellar nuclei (CN, red) contralateral-to-the-lesion. c Coronal section showing the injection site of retrograde CAV2-Cre-GFP in PF. Red dotted lines: needle’s trajectory. White dotted lines: limits of PF. Scale bar: 100 μm. d Coronal section showing the expression of anterograde hM4Di-mCherry in neurons (red) of CN. FN: fastigial nucleus; INant: interposed nucleus, anterior part; InDL: interposed nucleus, dorsolateral hump; Lat: lateral nucleus. Blue = DAPI; green = GFP and YFP; Red = mCherry. Scale bar: 100 μm. Insert: Postmortem histology showing hM4Di-mCherry-expressing neurons in (i) FN, (ii) IN, and (iii) DN. Scale bars: 20 µm. e Top . Pie chart representing the proportions of neurons in CN expressing hM4Di-mCherry (in magenta) and projecting to PF compared to other types of cells (in blue). Bottom . Boxplots showing the average distribution (in %) of the neurons expressing hM4Di-mCherry over the total number of cells (Ratio) in control animals (non-virally injected animals, in gray) and preventive animals either treated with saline (light blue) or CNO (dark blue). Gray dots represent individual data points present in the distribution f Boxplots showing the average scored of oral LID severity at the point time corresponding to 40 min after levodopa injection, 50 min after CNO injection and after theta-burst stimulations. Averaged score comprises the 4 weeks of cerebellar stimulation in two groups: preventive animals receiving saline (LID_PREV saline, N = 5), dark blue represents preventive animals receiving CNO (LID_PREV CNO, N = 6). Boxplots represent the median score (horizontal bars), the lower and the upper quartiles. Vertical lines represent median ± std. One-way Anova with two-sided Tukey HSD post-hoc test was used for 5e and non-parametric Kruskal-Wallis test with pairwise two-sided Wilcoxon test and a Benjamini & Hochberg correction were used for 5f. *** p < 0.001; ** p < 0.01; * p < 0.05; ns: p > 0.05. Source data are provided as a Source Data file. Schemes were taken from Franklin and Paxinos Brain Atlas, 3rd edition.

Article Snippet: Unless otherwise stated, data are presented as boxplots (from boxplot function in R Studio software 4.1.2).

Techniques: Injection, Expressing, Control, Saline

a Sagittal schematic showing neurons in the striatum expressing the dyskinetic marker FosB/ΔFosB (green). The cerebello-thalamo-cortical and cerebello-thalamo-striatal pathways are represented in mice expressing ChR2-YFP in Purkinje cells (PC + ChR2, green) as well as the injection site 6-OHDA or saline (gray). ST: Striatum; SNc: substantia nigra pars compacta ; M1: Primary motor cortex, VAL: Ventroanterior-ventrolateral complex of the thalamus, PF: Parafascicular nucleus of the thalamus, CN: cerebellar nuclei, CrusII: Crus2 of the ansiform lobule. Insets: Postmortem histology showing FosB-expressing neurons (i), DAPI (ii), and merged (iii). Scale bars: 20 µm. b Boxplots showing the ratio of cells expressing FosB between the striatum ipsilateral to the lesion and the striatum contralateral to the lesion in percentage (%) in the 4 different conditions (LID, magenta, N = 10; SHAM, gray, N = 10; and LID_PREV, blue, N = 10). Horizontal bars in boxplots represent the median. Magenta inset: Postmortem histology showing FosB-expressing neurons in dyskinetic animals in the striatum ipsilateral to the lesion ( left box ) and in the striatum contralateral to the lesion ( right box ). Scale bars: 20 µm. Blue inset: Postmortem histology showing FosB-expressing neurons in preventive animals in the striatum ipsilateral to the lesion ( left box ) and in the striatum contralateral to the lesion ( right box ). Scale bars: 20 µm. Boxplots represents the lower and the upper quartiles as well as the median. Vertical lines represent the median ± std. Isolated points represent outliers of the distribution. Two-sided student t test. *** p < 0.001; ** p < 0.01; * p < 0.05. *Compared to SHAM; # compared to LID. Source data are provided as a Source Data file. See also Table .

Journal: Nature Communications

Article Title: Cerebellar stimulation prevents Levodopa-induced dyskinesia in mice and normalizes activity in a motor network

doi: 10.1038/s41467-022-30844-0

Figure Lengend Snippet: a Sagittal schematic showing neurons in the striatum expressing the dyskinetic marker FosB/ΔFosB (green). The cerebello-thalamo-cortical and cerebello-thalamo-striatal pathways are represented in mice expressing ChR2-YFP in Purkinje cells (PC + ChR2, green) as well as the injection site 6-OHDA or saline (gray). ST: Striatum; SNc: substantia nigra pars compacta ; M1: Primary motor cortex, VAL: Ventroanterior-ventrolateral complex of the thalamus, PF: Parafascicular nucleus of the thalamus, CN: cerebellar nuclei, CrusII: Crus2 of the ansiform lobule. Insets: Postmortem histology showing FosB-expressing neurons (i), DAPI (ii), and merged (iii). Scale bars: 20 µm. b Boxplots showing the ratio of cells expressing FosB between the striatum ipsilateral to the lesion and the striatum contralateral to the lesion in percentage (%) in the 4 different conditions (LID, magenta, N = 10; SHAM, gray, N = 10; and LID_PREV, blue, N = 10). Horizontal bars in boxplots represent the median. Magenta inset: Postmortem histology showing FosB-expressing neurons in dyskinetic animals in the striatum ipsilateral to the lesion ( left box ) and in the striatum contralateral to the lesion ( right box ). Scale bars: 20 µm. Blue inset: Postmortem histology showing FosB-expressing neurons in preventive animals in the striatum ipsilateral to the lesion ( left box ) and in the striatum contralateral to the lesion ( right box ). Scale bars: 20 µm. Boxplots represents the lower and the upper quartiles as well as the median. Vertical lines represent the median ± std. Isolated points represent outliers of the distribution. Two-sided student t test. *** p < 0.001; ** p < 0.01; * p < 0.05. *Compared to SHAM; # compared to LID. Source data are provided as a Source Data file. See also Table .

Article Snippet: Unless otherwise stated, data are presented as boxplots (from boxplot function in R Studio software 4.1.2).

Techniques: Expressing, Marker, Injection, Saline, Isolation